Adaptive Methods: When and How Should They be Used in Clinical Trials?PORCHER, Raphaël; LECOCQ, Brigitte; VRAY, Muriel et al.Thérapie (Paris). 2011, Vol 66, Num 4, pp 319-326, issn 0040-5957, 8 p.Article

A model for the interim analysis process: a case studyDELGADO-HERRERA, Leticia; ANBAR, Dan.Controlled clinical trials. 2003, Vol 24, Num 1, pp 51-65, issn 0197-2456, 15 p.Article

Interim analysis in randomized trials: DAMOCLES' sword?BESSELINK, Marc G. H; VAN DER GRAAF, Yolanda; GOOSZEN, Hein G et al.Journal of clinical epidemiology. 2010, Vol 63, Num 4, pp 353-354, issn 0895-4356, 2 p.Article

Begründung der Wiederholung von Tierversuchen und Bestimmung der erforderlichen Tierzahl gemäss dem Deutschen Tierschutzgesetz = Justification of Repeated Animal Experiments and Determination of the Required Number of Animals According to the German Animal Protection ActSCHNEIDER, Berthold.Arzneimittel-Forschung. 2009, Vol 59, Num 6, pp 318-325, issn 0004-4172, 8 p.Article

Stopping a trial early in oncology : for patients or for industry?TROTTA, F; APOLONE, G; GARATTINI, S et al.Annals of oncology. 2008, Vol 19, Num 7, pp 1347-1353, issn 0923-7534, 7 p.Article

Cancer Genome Sequencing—An Interim AnalysisFOX, Edward J; SALK, Jesse J; LOEB, Lawrence A et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 12, issn 0008-5472, 4948-4950 [3 p.]Article

Les analyses intermédiaires = Interim analysis in clinical trialsCUCHERAT, M.La Lettre du pharmacologue (Boulogne). 2001, Vol 15, Num 1-2, pp 27-30, issn 0984-452XArticle

Update in methodology and conduct of cancer clinical trialsTHERASSE, P; EISENHAUER, E. A; BUYSE, M et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1322-1330, issn 0959-8049, 9 p.Article

Group sequential T-test for clinical trials with small sample sizes across stagesJUN SHAO; HUAIBAO FENG.Contemporary clinical trials. 2007, Vol 28, Num 5, pp 563-571, issn 1551-7144, 9 p.Article

Some remarks about the analysis of active control studiesLAWRENCE, John.Biometrical journal. 2005, Vol 47, Num 5, pp 616-622, issn 0323-3847, 7 p.Article

Monitoring mortality at interim analyses while testing a composite endpoint at the final analysisCHEN, Y. H; DEMETS, David L; GORDON LAN, K. K et al.Controlled clinical trials. 2003, Vol 24, Num 1, pp 16-27, issn 0197-2456, 12 p.Article

Sample size reestimation in clinical trialsZHENMING SHUN.Drug information journal. 2001, Vol 35, Num 4, pp 1409-1422, issn 0092-8615Article

Application of adaptive interim analysis in pharmacology : Statistical Methodology in Non-Clinical & Toxicological StudiesHOTHORN, L. A; MARTIN, U.Drug information journal. 1997, Vol 31, Num 2, pp 615-619, issn 0092-8615Conference Paper

From Trial and Error to Trial Simulation III: A Framework for Interim Analysis in Efficacy Trials With Antidepressant DrugsSANTEN, G; ZWET, Evan; BETTICA, P et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 4, pp 602-607, issn 0009-9236, 6 p.Article

Early stopping of randomized clinical trials for overt efficacy is problematic. CommentarySYDES, Matthew R; PARMAR, Mahesh K. B; BASSLER, Dirk et al.Journal of clinical epidemiology. 2008, Vol 61, Num 3, issn 0895-4356, 203-204, 241-246 [8 p.]Article

Clinical trials with an adaptive choice of hypothesesHOMMEL, Gerhard; KROPF, Siegfried.Drug information journal. 2001, Vol 35, Num 4, pp 1423-1429, issn 0092-8615Article

Small Sample Approach, and Statistical and Epidemiological AspectsOFFRINGA, Martin; DER LEE, Hanneke Van.Handbook of experimental pharmacology. 2011, Vol 205, pp 181-202, issn 0171-2004, 22 p.Article

Completeness and unbiased estimation of mean vector in the multivariate group sequential caseAIYI LIU; CHENGQING WU; YU, Kai F et al.Journal of multivariate analysis. 2007, Vol 98, Num 3, pp 505-516, issn 0047-259X, 12 p.Article

Randomised controlled trials in oncology closed early for benefit: Trends in methodology, results, and interpretationBOOTH, Christopher M; OHORODNYK, Pavlo; LITING ZHU et al.European journal of cancer (1990). 2011, Vol 47, Num 6, pp 854-863, issn 0959-8049, 10 p.Article

Les méthodes adaptatives: quand et comment les utiliser dans les essais cliniques ?PORCHER, Raphaël; LECOCQ, Brigitte; VRAY, Muriel et al.Thérapie (Paris). 2011, Vol 66, Num 4, pp 309-317, issn 0040-5957, 9 p.Article

Survival endpoints and adaptive designsBAUER, Peter.Biometrical journal. 2006, Vol 48, Num 4, pp 730-731, issn 0323-3847, 2 p.Article

A new interim monitoring statistic for group sequential clinical trialsMOSER, Barry K; TEBBS, Joshua M.Communications in statistics. Theory and methods. 2004, Vol 33, Num 1, pp 153-164, issn 0361-0926, 12 p.Article

Adaptive trial design : A general methodology for censored time to event dataJAHN-EIMERMACHER, Antje; INGEL, Katharina.Contemporary clinical trials. 2009, Vol 30, Num 2, pp 171-177, issn 1551-7144, 7 p.Article

Bayesian interim analysis in clinical trialsXIAO ZHANG; CUTTER, Gary.Contemporary clinical trials. 2008, Vol 29, Num 5, pp 751-755, issn 1551-7144, 5 p.Article

Predicting the duration of sequential survival studiesWHITEHEAD, John.Drug information journal. 2001, Vol 35, Num 4, pp 1387-1400, issn 0092-8615Article